Trial Details

Not Recruiting
Basic Information
Clinical ID c5047
Identifier IRCT201410062709N30
Trial Title The effect of urtica dioica leaf extract on tumor necrosis factor alpha, high- sensitivity C- reactive protein, superoxide dismutase, erythrocyte sedimentation rate, blood cell count, calprotectin and quality of life in patient with inflammatory bowel d
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory bowel disease. Crohn disease of small intestine, Ulcerative colitis;K50, K51;Crohn disease of small intestine, Ulcerative colitis
Interventions Intervention 1: Stinging nettle tablet, produced in the company of barijessence, 400 mg tablet, three times a day for 3 months in intervention group. Intervention 2: Placebo, tablets containing starch, produced in Tehran University of Medical Sciences, 40
Participant Information
Sponsor Vice chancellor for research, Iran University of Medical Sciences
City NULL
Country/Region Iran
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL